2018 annual financial data
Kymera Therapeutics 2018 Operating margin
Kymera Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -21,451,000 USD and net income was -21,467,000 USD.
Operating cash flow was -17,863,000 USD.
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -21,451,000 USD
- Net income
- -21,467,000 USD
- Operating cash flow
- -17,863,000 USD